LOGIN
Evicel fibrin sealant does not appear to reduce total blood loss/transfusion rates for TKA
October 2014
Evicel fibrin sealant does not appear to reduce total blood loss/transfusion rates for TKA
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Is the Newest Fibrin Sealant an Effective Strategy to Reduce Blood Loss After Total Knee Arthroplasty? A Randomized Controlled Study
J Arthroplasty. 2014 Aug;29(8):1516-20Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
62 patients scheduled to undergo primary TKA for knee osteoarthritis were randomly allocated to receive a topical application of a novel fibrin sealant (Evicel) or standard treatment (no application of Evicel), with the purpose of examining its ability to limit blood loss and reduce the need for blood transfusions. Results of this trial revealed Evicel does not reduce total blood loss or transfusi...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.